Oxford-AstraZeneca researchers attempt to battle variants
Researchers at Oxford-AstraZeneca are working on a more effective shot to tackle new coronavirus variants. The testing comes as the company conducts U.S. trials to present for FDA approval. CBS News foreign correspondent Charlie D'Agata reports.
UP NEXT
UP NEXT
-
California governor addresses reopening schools
CBS News
-
No charges for Capitol officer who fatally shot protester
CBS News
-
Defense's medical expert classifies George Floyd's manner of death as "undetermined"
CBS News
-
Brooklyn Center, Minnesota, residents mourn death of Daunte Wright
CBS News
-
New details revealed about Congressman Gaetz's 2018 Bahamas trip
CBS News
-
Trump-era border policy still being used to expel migrants from U.S.
CBS News
-
U.S. climate envoy John Kerry has talks in China
CBS News
-
CDC panel needs more time to weigh risks of Johnson & Johnson's coronavirus vaccine
CBS News
-
Local Matters: Representative Mo Brooks, Republican who sparked controversy at January 6 Trump rally, emerges as top contender in Alabama Senate Primary
CBS News
-
Intel officials to Senate committee: China and Russia pose greatest threat to U.S.
CBS News
-
Biden creates commission to review Supreme Court reforms as Democrats grapple with future of the High Court
CBS News
-
Biden to withdraw U.S. troops from Afghanistan by 9/11
CBS News
-
Kristin Smart killed during 1996 rape attempt, prosecutor says
CBS News
-
Brazil grapples with surging COVID deaths and hospitalizations
CBS News
-
COVID-19 "long-haulers" cope with lasting virus symptoms
CBS News
-
Former daughter-in-law of Trump Org CFO says she has "boxes and boxes" of financial documents after bitter divorce
CBS News